معرفی
Thomas Weimbs is a Professor in the Department of Molecular, Cellular, and Developmental Biology at the University of California, Santa Barbara. His research focuses on understanding the molecular mechanisms underlying kidney diseases, particularly polycystic kidney disease (PKD) and chronic kidney disease (CKD), and developing therapies based on metabolic interventions such as ketogenic diets. His lab investigates how ketosis—induced by low-carbohydrate diets—modulates cellular pathways to slow disease progression. Weimbs has launched a startup, Santa Barbara Nutrients, to translate research into medical foods like KetoCitra and the Ren-Nu program, which provide nutritional strategies for PKD patients. He emphasizes the role of diet and lifestyle in managing kidney health, challenging traditional protein-restriction paradigms. His work bridges basic science and clinical applications, with a strong focus on patient-centered therapies.
- Research Interests: Polycystic kidney disease, metabolic therapy, renal cystogenesis, ketosis, and kidney healthspan.
- Key Projects: Development of Ketogenic Metabolic Therapy (KMT) programs, analysis of crystal-induced cyst formation, and GPR109A signaling pathways.
- Startup Involvement: Co-founded Santa Barbara Nutrients to commercialize research findings into medical foods and dietary programs.
Weimbs collaborates with clinicians and industry to implement therapies, such as the Ren-Nu program, which combines nutrition and lifestyle changes to improve kidney function. His research also explores the role of dietary supplements like citrate and beta-hydroxybutyrate in mitigating disease progression. He actively communicates findings through academic publications, public talks, and social media, advocating for evidence-based nutritional approaches in kidney care.
